BR112013028789A2 - processo - Google Patents
processoInfo
- Publication number
- BR112013028789A2 BR112013028789A2 BR112013028789A BR112013028789A BR112013028789A2 BR 112013028789 A2 BR112013028789 A2 BR 112013028789A2 BR 112013028789 A BR112013028789 A BR 112013028789A BR 112013028789 A BR112013028789 A BR 112013028789A BR 112013028789 A2 BR112013028789 A2 BR 112013028789A2
- Authority
- BR
- Brazil
- Prior art keywords
- processes
- compound
- formula
- preparation
- relates
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
- C07C309/08—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
- C07C55/07—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1107985.2A GB201107985D0 (en) | 2011-05-13 | 2011-05-13 | Process |
| PCT/GB2012/051037 WO2012156693A1 (en) | 2011-05-13 | 2012-05-11 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013028789A2 true BR112013028789A2 (pt) | 2016-08-09 |
Family
ID=44260448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013028789A BR112013028789A2 (pt) | 2011-05-13 | 2012-05-11 | processo |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20140364601A1 (https=) |
| EP (1) | EP2707362A1 (https=) |
| JP (1) | JP2014520075A (https=) |
| KR (1) | KR20140045380A (https=) |
| CN (1) | CN103649060A (https=) |
| AU (1) | AU2012257630A1 (https=) |
| BR (1) | BR112013028789A2 (https=) |
| CA (1) | CA2835237A1 (https=) |
| GB (1) | GB201107985D0 (https=) |
| IL (1) | IL229126A0 (https=) |
| MX (1) | MX2013012484A (https=) |
| RU (1) | RU2013148907A (https=) |
| SG (1) | SG194631A1 (https=) |
| WO (1) | WO2012156693A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3192B1 (ar) | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| CN103193658A (zh) * | 2013-04-18 | 2013-07-10 | 苏州永健生物医药有限公司 | 一种（r）-2-对硝基苯乙胺基-1-苯乙醇及其盐的合成方法 |
| TWI685497B (zh) | 2014-06-02 | 2020-02-21 | 西班牙商伊史帝夫製藥公司 | 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物 |
| TW201615642A (zh) * | 2014-06-02 | 2016-05-01 | 伊史帝夫博士實驗室股份有限公司 | 具有多重模式抗疼痛活性的１－氧雜－４，９－二氮雜螺十一烷化合物之醯胺衍生物 |
| AR106697A1 (es) | 2015-11-16 | 2018-02-07 | Esteve Labor Dr | Compuestos oxadiazoespíricos para el tratamiento del abuso y la adicción a las drogas |
| MY200894A (en) | 2017-10-17 | 2024-01-22 | Esteve Pharmaceuticals Sa | Salts of (r)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1158277C (zh) | 1998-02-02 | 2004-07-21 | Lg化学株式会社 | 具有哌啶结构的法尼转移酶抑制剂及其制备方法 |
| PE20050130A1 (es) | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
| GB0218629D0 (en) * | 2002-08-09 | 2002-09-18 | Novartis Ag | Organic compounds |
| TW200738659A (en) | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| CN101300239A (zh) * | 2005-08-29 | 2008-11-05 | 阿斯利康(瑞典)有限公司 | 作为β2肾上腺素受体激动剂的7-（2-氨基-1-羟基-乙基）-4-羟基苯并噻唑-2(3H)-酮衍生物 |
| HRP20120968T1 (hr) | 2008-02-06 | 2013-01-31 | Astrazeneca Ab | Spojevi |
-
2011
- 2011-05-13 GB GBGB1107985.2A patent/GB201107985D0/en not_active Ceased
-
2012
- 2012-05-11 AU AU2012257630A patent/AU2012257630A1/en not_active Abandoned
- 2012-05-11 KR KR1020137032749A patent/KR20140045380A/ko not_active Withdrawn
- 2012-05-11 US US14/117,259 patent/US20140364601A1/en not_active Abandoned
- 2012-05-11 JP JP2014509829A patent/JP2014520075A/ja not_active Withdrawn
- 2012-05-11 MX MX2013012484A patent/MX2013012484A/es not_active Application Discontinuation
- 2012-05-11 RU RU2013148907/04A patent/RU2013148907A/ru not_active Application Discontinuation
- 2012-05-11 CA CA2835237A patent/CA2835237A1/en not_active Abandoned
- 2012-05-11 EP EP12722808.8A patent/EP2707362A1/en not_active Withdrawn
- 2012-05-11 BR BR112013028789A patent/BR112013028789A2/pt not_active IP Right Cessation
- 2012-05-11 CN CN201280034581.XA patent/CN103649060A/zh active Pending
- 2012-05-11 SG SG2013079363A patent/SG194631A1/en unknown
- 2012-05-11 WO PCT/GB2012/051037 patent/WO2012156693A1/en not_active Ceased
-
2013
- 2013-10-28 IL IL229126A patent/IL229126A0/en unknown
-
2015
- 2015-09-17 US US14/857,254 patent/US20160002261A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB201107985D0 (en) | 2011-06-29 |
| EP2707362A1 (en) | 2014-03-19 |
| US20160002261A1 (en) | 2016-01-07 |
| AU2012257630A1 (en) | 2013-11-28 |
| MX2013012484A (es) | 2014-01-24 |
| WO2012156693A1 (en) | 2012-11-22 |
| SG194631A1 (en) | 2013-12-30 |
| US20140364601A1 (en) | 2014-12-11 |
| IL229126A0 (en) | 2013-12-31 |
| CA2835237A1 (en) | 2012-11-22 |
| JP2014520075A (ja) | 2014-08-21 |
| RU2013148907A (ru) | 2015-06-20 |
| KR20140045380A (ko) | 2014-04-16 |
| CN103649060A (zh) | 2014-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014007193A2 (pt) | derivados de pirazoloquinolinona, preparação dos mesmos e uso terapêutico dos mesmos | |
| BR112014011594A2 (pt) | anticorpos anti-il-36r | |
| BR112014009866A2 (pt) | formulações de anticorpos e métodos | |
| BR112014000236A2 (pt) | lipossomas com razão n:p útil para a liberação de moléculas de rna, composição e uso de ditos lipossomas | |
| BR112013031405A2 (pt) | piridopirazinas substituídas como novos inibidores de syk | |
| BR112013025680A2 (pt) | Novos intermediários e processos para preparar ticagrelor | |
| BR112012020791A2 (pt) | produção de 6'-o-sialillactose e intermediários | |
| BR112014005025A2 (pt) | composição farmacêutica para uso no tratamento de uma doença neurodegenerativa | |
| CL2013001947A1 (es) | Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona. | |
| BR112015001101A2 (pt) | formas cristalinas de um inibidor de prolil hidroxilase | |
| BR112013020767A2 (pt) | composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo | |
| BR112015009649A2 (pt) | composto de triazolo | |
| BR112014013108A2 (pt) | compostos tricíclicos fundidos como inibidores da quinase raf | |
| BR112014003587A2 (pt) | derivados de 5-flúor-4-imino-3-(substituído)-3,4-di-hidropirimidin-2(1h)ona | |
| BR112014003079A2 (pt) | derivado de 1,2,3,4-tetra-hidroquinolina útil para o tratamento de diabetes | |
| CR20140134A (es) | Composiciones farmacéuticas | |
| BR112013022052A2 (pt) | ligantes antagonísticos de dr3 | |
| BR112013030833A2 (pt) | processo para a preparação de um composto de formula (i) e processo para a preparação de estetrol | |
| GT201300084A (es) | Conjugado de naloxol-peg cristalino | |
| BR112015012825A2 (pt) | piridopirazinas substituídas como inibidores de syk | |
| WO2012104823A3 (en) | Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases | |
| BR112015002275A2 (pt) | processos e intermediários para a preparação de inibidores da integrase | |
| BR112013028789A2 (pt) | processo | |
| BR112014012459A2 (pt) | 2h-indazóis como antagonistas do receptor de ep2 | |
| BR112015003957A2 (pt) | alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |